| 000 | 00878 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250514214015.0 | ||
| 264 | 0 | _c20050418 | |
| 008 | 200504s 0 0 eng d | ||
| 022 | _a1424-6074 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMöritz, A | |
| 245 | 0 | 0 |
_aIndustry perspective for biotech products. _h[electronic resource] |
| 260 |
_bDevelopments in biologicals _c2004 |
||
| 300 |
_a37-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xisolation & purification |
| 650 | 0 | 4 |
_aBiological Products _xstandards |
| 650 | 0 | 4 | _aBiotechnology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aDNA, Recombinant _xisolation & purification |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 |
_aViruses _xisolation & purification |
| 773 | 0 |
_tDevelopments in biologicals _gvol. 118 _gp. 37-44 |
|
| 999 |
_c15325149 _d15325149 |
||